Cellestis

Companies Cellestis

News Cellestis

• QIAGEN completes acquisition of Cellestis Limited

  QIAGEN N.V.  announced that its acquisition of all the ordinary shares in Cellestis Limited by a way of a scheme of arrangement (“Scheme”) has been implemented.The closing of the transaction follows the official approval of Cellestis’ shareholders and Australian courts. QIAGEN had announced the init more

• QIAGEN updates proposal to acquire Cellestis

  QIAGEN N.V. announced that it has amended its original proposal to acquire Cellestis Limited, a publicly traded Australian biotechnology company.Under terms of the amended proposal, the per-share offer price is being increased by 7% to A$3.80 from the original offer price of A$3.55 announced on Apri more

• QIAGEN makes proposal to acquire Australian diagnostics company Cellestis Limited

  QIAGEN N.V. has reached an agreement to acquire Cellestis Limited for approximately A$341 million (US$355 million) in cash, providing QIAGEN with access to a novel “pre-molecular” technology that offers a new dimension in disease detection not currently possible with other diagnostic methods.The acq more

Publications Cellestis

• Research Note: Interferon‐γ release assay in people infected with immunodeficiency virus

  Clin Microbiol Infect 2011; 17: 402–404 Abstract The present study aimed to use QuantiFERON TB Gold in tube (Cellestis Limited, Carnegie, Victoria, Australia) as a tool for the screening for tubercular infection in HIV‐positive patients. Seventy‐three HIV‐positive subjects were tested. For more

Market studies Cellestis

• Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

  Introduction ”Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Greece In Vitro Diagnostics market. The report provides value (USD million), for each segment and sub-segment within seven mark more

• Hungary In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

  Introduction ”Hungary In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Hungary In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seve more

• Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

  Introduction ”Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Norway In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven more

Websites Cellestis